Admera Health Announces Availability of Psychiatric Specific Report, PGxPsych™, for its PGxOne™ Plus Pharmacogenomics Test
South Plainfield, NJ – June 26, 2018 - Today, Admera Health (www.admerahealth.com), announced the availability of a psychiatric specific report for its PGxOne™ Plus pharmacogenomics test. PGxOne™ Plus is a laboratory developed test that includes over 50 genes, over 200 DNA variants (affecting drug metabolism, transportation, and activation), and provides [...]
Admera Health Launches New Tests for Cancer Supportive Care and Liquid Biopsy, Now Provides a Comprehensive Portfolio of Oncology Products
SOUTH PLAINFIELD, N.J., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health (www.admerahealth.com) announced the launch of multiple laboratory developed tests: PGxOnco™, for cancer supportive care, and LiquidGx™, a suite of liquid biopsy based tests for tumor profiling and drug resistance monitoring. Admera initially unveiled these tests on October [...]
Admera Health Expands Asian Footprint with Three Strategic Partnerships
South Plainfield, NJ – September 12, 2017 – Today, Admera Health announced agreements expanding Admera’s portfolio of molecular diagnostics to Asia, including but not limited to Singapore, Hong Kong, Korea and Taiwan. Admera Health, a molecular diagnostic company, offers the most comprehensive pharmacogenomics testing services available, its PGxOne™ Plus [...]
New York Medical College and Touro College of Pharmacy Team to Offer Pharmacogenomics CME Course Sponsored by Admera Health
Valhalla, NY and South Plainfield, NJ – August 8, 2017 – Today, New York Medical College and Touro College of Pharmacy announced the wider availability of their joint Continuing Medical Education (CME) course, Principles of Genomics and Introduction to Personalized Medicine. The course which premiered live on March 21st, [...]
Columbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric Medications
SOUTH PLAINFIELD, NJ – July 25, 2017 - Admera Health, an advanced molecular diagnostic laboratory, has been selected by Columbia University Medical Center’s Center for Biomedical Informatics to supply its powerful 50-gene pharmacogenomic testing panel for major study to test comprehensive pharmacogenomic testing on treatment of major depressive disorders. The [...]